Today we are pleased to welcome Tempo Therapeutics to the Nolqa portfolio. We invested $640K to support the company as it builds its next stage of growth.
What Tempo Therapeutics does
Tempo Therapeutics develops regenerative medicine technologies designed to support tissue repair. Its work includes tissue scaffold products and clinical development aimed at addressing difficult medical problems with new therapeutic approaches.
Why we invested
We invested because regenerative medicine combines significant unmet need with the potential for technology to change how tissue repair is approached. Tempo is working on a focused platform and advancing toward clinical applications, creating a clear path from scientific innovation to patient impact.
What comes next
We look forward to supporting Tempo as it advances its programs, clinical development and partnerships in regenerative medicine.
We are looking forward to working closely with the team and helping Tempo Therapeutics build the next chapter of the business.